Enhancers of adeno-associated virus AAV2 transduction via high throughput siRNA screening

Molecular Therapy

Volumn 19, Issue 6, 2011, Pages 1152-1160

  Wallen, Alexis J ^a   Barker, Gregory A ^a   Fein, David E ^a   Jing, Huiyan ^a   Diamond, Scott L ^a,b  

^a Institute for Medicine and Engineering   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON RECEPTOR; BETA INTERFERON RECEPTOR; CYTOKINE; INTERFERON; INTERFERON INDUCED MYXOVIRUS RESISTANCE 1 PROTEIN; INTERFERON INDUCED PROTEIN 44 LIKE; INTERFERON INDUCED PROTEIN WITH TETRATRICOPEPTIDE REPEAT; MESSENGER RNA; MICRORNA; PARVOVIRUS VECTOR; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ADENO ASSOCIATED VIRUS; ADENO ASSOCIATED VIRUS 2; ARTERY ENDOTHELIUM; ARTICLE; CELL CULTURE; CLIC2 GENE; CONTROLLED STUDY; ENDOTHELIUM CELL; EPITHELIUM CELL; GENE; GENE EXPRESSION; GENE LIBRARY; GENE SILENCING; GENE TARGETING; GENETIC SCREENING; GENETIC TRANSCRIPTION; GENETIC TRANSDUCTION; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; POINT MUTATION; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY EPITHELIUM; RNA SEQUENCE; SLC13A4 GENE; SLC5A2 GENE; SLC5A3 GENE; VIRAL GENE DELIVERY SYSTEM;

ADENO-ASSOCIATED VIRUS; ORTHOMYXOVIRIDAE;

EID: 79957891373     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2011.4     Document Type: Article

References (40)

1. Hoggan, MD, Blacklow, NR and Rowe, WP (1966). Studies of small DNA viruses found in various adenovirus preparations: physical, biological, and immunological characteristics. Proc Natl Acad Sci USA 55: 1467-1474.
2. Bartlett, JS, Samulski, RJ and McCown, TJ (1998). Selective and rapid uptake of adeno-associated virus type 2 in brain. Hum Gene Ther 9: 1181-1186. (Pubitemid 28269004)
3. Chao, H, Liu, Y, Rabinowitz, J, Li, C, Samulski, RJ and Walsh, CE (2000). Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors. Mol Ther 2: 619-623.
4. Mehendale, S, van Lunzen, J, Clumeck, N, Rockstroh, J, Vets, E, Johnson, PR et al. (2008). A phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C adeno-associated virus vaccine. AIDS Res Hum Retroviruses 24: 873-880. (Pubitemid 351871679)
5. Flotte, TR, Zeitlin, PL, Reynolds, TC, Heald, AE, Pedersen, P, Beck, S et al. (2003). Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fbrosis patients: a two-part clinical study. Hum Gene Ther 14: 1079-1088. (Pubitemid 36851399)
6. Moss, RB, Milla, C, Colombo, J, Accurso, F, Zeitlin, PL, Clancy, JP et al. (2007). Repeated aerosolized AAV-CFTR for treatment of cystic fbrosis: a randomized placebo-controlled phase 2B trial. Hum Gene Ther 18: 726-732. (Pubitemid 47378069)
7. Aitken, ML, Moss, RB, Waltz, DA, Dovey, ME, Tonelli, MR, McNamara, SC et al. (2001). A phase I study of aerosolized administration of tgAAVCF to cystic fbrosis subjects with mild lung disease. Hum Gene Ther 12: 1907-1916. (Pubitemid 32947233)
8. Manno, CS, Chew, AJ, Hutchison, S, Larson, PJ, Herzog, RW, Arruda, VR et al. (2003). AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B. Blood 101: 2963-2972. (Pubitemid 36857981)
9. Summerford, C and Samulski, RJ (1998). Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J Virol 72: 1438-1445. (Pubitemid 28116931)
10. Sanlioglu, S, Benson, PK, Yang, J, Atkinson, EM, Reynolds, T and Engelhardt, JF (2000). Endocytosis and nuclear traffcking of adeno-associated virus type 2 are controlled by rac1 and phosphatidylinositol-3 kinase activation. J Virol 74: 9184-9196.
11. Brass, AL, Dykxhoorn, DM, Benita, Y, Yan, N, Engelman, A, Xavier, RJ et al. (2008). Identifcation of host proteins required for HIV infection through a functional genomic screen. Science 319: 921-926. (Pubitemid 351263756)
12. König, R, Zhou, Y, Elleder, D, Diamond, TL, Bonamy, GM, Irelan, JT et al. (2008). Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell 135: 49-60.
13. Ng, TI, Mo, H, Pilot-Matias, T, He, Y, Koev, G, Krishnan, P, Mondal, R et al. (2007) Identifcation of host genes involved in hepatitis C virus replication by small interfering RNA technology. Hepatology 45: 1413-1421. (Pubitemid 46918325)
14. Tai, AW, Benita, Y, Peng, LF, Kim, SS, Sakamoto, N, Xavier, RJ et al. (2009). A functional genomic screen identifes cellular cofactors of hepatitis C virus replication. Cell Host Microbe 5: 298-307.
15. Supekova, L, Supek, F, Lee, J, Chen, S, Gray, N, Pezacki, JP et al. (2008). Identifcation of human kinases involved in hepatitis C virus replication by small interference RNA library screening. J Biol Chem 283: 29-36.
16. Krishnan, MN, Ng, A, Sukumaran, B, Gilfoy, FD, Uchil, PD, Sultana, H et al. (2008). RNA interference screen for human genes associated with West Nile virus infection. Nature 455: 242-245.
17. Clemente, R, Sisman, E, Aza-Blanc, P and de la Torre, JC (2010). Identifcation of host factors involved in borna disease virus cell entry through a small interfering RNA functional genetic screen. J Virol 84: 3562-3575.
18. Jackson, AL, Bartz, SR, Schelter, J, Kobayashi, SV, Burchard, J, Mao, M et al. (2003). Expression profling reveals off-target gene regulation by RNAi. Nat Biotechnol 21: 635-637. (Pubitemid 36638089)
19. Jackson, AL and Linsley, PS (2004). Noise amidst the silence: off-target effects of siRNAs? Trends Genet 20: 521-524. (Pubitemid 39314555)
20. Lin, X, Ruan, X, Anderson, MG, McDowell, JA, Kroeger, PE, Fesik, SW et al. (2005). siRNA-mediated off-target gene silencing triggered by a 7 nt complementation. Nucleic Acids Res 33: 4527-4535. (Pubitemid 41222567)
21. Qiu, S, Adema, CM and Lane, T (2005). A computational study of off-target effects of RNA interference. Nucleic Acids Res 33: 1834-1847. (Pubitemid 41748330)
22. Birmingham, A, Anderson, EM, Reynolds, A, Ilsley-Tyree, D, Leake, D, Fedorov, Y et al. (2006). 3' UTR seed matches, but not overall identity, are associated with RNAi off-targets. Nat Methods 3: 199-204.
23. Ma, Y, Creanga, A, Lum, L and Beachy, PA (2006). Prevalence of off-target effects in Drosophila RNA interference screens. Nature 443: 359-363. (Pubitemid 44435157)
24. Anderson, E, Boese, Q, Khvorova, A, Karpilow, J (2008). Identifying siRNA-induced off-targets by microarray analysis. In: Barik S (ed). RNAi Design and Application. Humana Press: Totowa, NJ. 442: 45-63.
25. Fedorov, Y, Anderson, EM, Birmingham, A, Reynolds, A, Karpilow, J, Robinson, K et al. (2006). Off-target effects by siRNA can induce toxic phenotype. RNA 12: 1188-1196. (Pubitemid 43990544)
26. Barker, GA and Diamond, SL (2008). RNA interference screen to identify pathways that enhance or reduce nonviral gene transfer during lipofection. Mol Ther 16: 1602-1608.
27. Zhang, XD, Yang, XC, Chung, N, Gates, A, Stec, E, Kunapuli, P et al. (2006). Robust statistical methods for hit selection in RNA interference high-throughput screening experiments. Pharmacogenomics 7: 299-309.
28. Biron, CA (1999). Initial and innate responses to viral infections-pattern setting in immunity or disease. Curr Opin Microbiol 2: 374-381. (Pubitemid 29366958)
29. Perry, AK, Chen, G, Zheng, D, Tang, H and Cheng, G (2005). The host type I interferon response to viral and bacterial infections. Cell Res 15: 407-422. (Pubitemid 41642869)
30. Taniguchi, T and Takaoka, A (2002). The interferon-α/ß system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors. Curr Opin Immunol 14: 111-116. (Pubitemid 34085114)
31. Zhu, J, Huang, X and Yang, Y (2009). The TLR9-MyD88 pathway is critical for adaptive immune responses to adeno-associated virus gene therapy vectors in mice. J Clin Invest 119: 2388-2398.
32. Biron, CA (1998). Role of early cytokines, including α and ß interferons (IFN-α/ß), in innate and adaptive immune responses to viral infections. Semin Immunol 10: 383-390. (Pubitemid 28499552)
33. Darnell, JE Jr, Kerr, IM and Stark, GR (1994). Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264: 1415-1421. (Pubitemid 24217131)
34. Khabar, KS, Siddiqui, YM, al-Zoghaibi, F, al-Haj, L, Dhalla, M, Zhou, A et al. (2003). RNase L mediates transient control of the interferon response through modulation of the double-stranded RNA-dependent protein kinase PKR. J Biol Chem 278: 20124-20132. (Pubitemid 36799207)
35. Kimball, SR (1999). Eukaryotic initiation factor eIF2. Int J Biochem Cell Biol 31: 25-29. (Pubitemid 29094786)
36. Yoshida, J, Mizuno, M, Nakahara, N and Colosi, P (2002). Antitumor effect of an adeno-associated virus vector containing the human interferon-ß gene on experimental intracranial human glioma. Jpn J Cancer Res 93: 223-228. (Pubitemid 34223767)
37. Streck, CJ, Dickson, PV, Ng, CY, Zhou, J, Hall, MM, Gray, JT et al. (2006). Antitumor effcacy of AAV-mediated systemic delivery of interferon-β. Cancer Gene Ther 13: 99-106. (Pubitemid 41816354)
38. Shih, CS, Laurie, N, Holzmacher, J, Spence, Y, Nathwani, AC, Davidoff, AM et al. (2009). AAV-mediated local delivery of interferon-β for the treatment of retinoblastoma in preclinical models. Neuromolecular Med 11: 43-52.
39. Calcedo, R, Vandenberghe, LH, Gao, G, Lin, J and Wilson, JM (2009). Worldwide epidemiology of neutralizing antibodies to adeno-associated viruses. J Infect Dis 199: 381-390.
40. Tusher, VG, Tibshirani, R and Chu, G (2001). Signifcance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98: 5116-5121 (Pubitemid 32397092)